In vitro digestion and fermentation by human fecal microbiota of polysaccharides from Clitocybe squamulose

Int J Biol Macromol. 2022 May 31:208:343-355. doi: 10.1016/j.ijbiomac.2022.03.126. Epub 2022 Mar 22.

Abstract

The present study aimed to evaluate the effects of in vitro simulated saliva-gastrointestinal digestion and fecal fermentation behavior on the chemical composition, structure and bioactivity of polysaccharides from Clitocybe squamulosa (CSFP). Results showed that gastric digestion significantly changed the chemical composition and structural properties of CSFP, such as total uronic acid, reducing sugar, molecular weight, rheological properties, particle size, and microscopic morphology. In particular, the molecular weight decreased from 19,480 Da to 10,945 Da, while the reducing-sugar content increased from 0.149 mg/mL to 0.293 mg/mL. Gastric digestion also affected the biological activity of CSFP. Although after gastric digestion, CSFP retained its vigorous antioxidant activity, ability to inhibit α-amylase activity, and the binding ability to bile acid, fat, and free cholesterol in vitro. However, there was an apparent weakening trend. After in vitro fermentation of gut microbiota, the content of total sugar was significantly decreased from 11.6 mg/mL to 2.4 mg/mL, and the pH value in the fecal culture significantly decreased to 5.20, indicating that CSFP could be broken down and utilized by gut microbiota. Compared to the blank, the concentrations of total short-chain fatty acids (SCFAs) including acetic, propionic and n-butyric significantly increased. Simultaneously, CSFP could remarkably reduce the proportions of Firmicutes and Bacteroides (F/B) and promote the growth of some beneficial intestinal microbiota. Therefore, CSFP can potentially be a new functional food as prebiotics to promote human gut health.

Keywords: Clitocybe squamulosa; Fecal fermentation; Gut microbiota; In vitro digestion.

MeSH terms

  • Digestion*
  • Fatty Acids, Volatile / metabolism
  • Feces
  • Fermentation
  • Humans
  • Microbiota*
  • Polysaccharides / metabolism
  • Polysaccharides / pharmacology
  • Sugars / pharmacology

Substances

  • Fatty Acids, Volatile
  • Polysaccharides
  • Sugars